IDEXX Laboratories Reduces Dimensional Fund Advisors Stake

Institutional investor sells over 13,000 shares of the veterinary diagnostics company

Published on Mar. 6, 2026

Got story updates? Submit your updates here. ›

Dimensional Fund Advisors LP reduced its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 2.3% during the 3rd quarter, according to the company's recent SEC filing. The institutional investor now owns 544,185 shares of the company's stock, valued at approximately $347.6 million.

Why it matters

IDEXX Laboratories is a leading provider of diagnostic products and services for the animal health, water testing, and food safety markets. The reduction in Dimensional Fund Advisors' stake could signal a shift in investor sentiment or portfolio rebalancing, which may impact the stock price and market perception of the company.

The details

Dimensional Fund Advisors sold 13,001 shares of IDEXX Laboratories during the 3rd quarter, reducing its total position to 544,185 shares. The institutional investor now owns approximately 0.68% of the company's outstanding shares.

  • Dimensional Fund Advisors reduced its IDEXX Laboratories position during the 3rd quarter of 2026.

The players

Dimensional Fund Advisors LP

An institutional investment management firm that provides a range of equity, fixed income, and alternative investment strategies.

IDEXX Laboratories, Inc.

A global developer, manufacturer, and provider of diagnostic products and services primarily for the animal health, water testing, and food safety markets.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Dimensional Fund Advisors' stake in IDEXX Laboratories could signal a broader shift in investor sentiment or portfolio rebalancing, which may impact the stock price and market perception of the company. However, IDEXX remains a leading provider of veterinary diagnostics and services, and its long-term growth prospects continue to be positive.